| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Peninsula Medical School, Institute of Biomedical and Clinical Science, John Bull Building, Plymouth PL6 8BU, UK
(Correspondence should be addressed to N G Morgan; Email: noel.morgan{at}pms.ac.uk)
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
(eIF2) kinase (PERK)-dependent pathway of ER stress (phospho-eIF2; ATF4, activating transcription factor 4 and C/EBP homologous protein (CHOP-10)) although it failed to promote the expression of the ER chaperone GRP78. By contrast, palmitoleate did not induce any markers of the ER stress pathway even at concentrations as high as 1 mM. When palmitate and palmitoleate were added in combination, a marked attenuation of the ER stress response occurred. Under these conditions, the levels of phospho-eIF2, ATF4 and CHOP-10 were reduced to less than those found in control cells. Palmitoleate also attenuated the ER stress response to the protein glycosylation inhibitor, tunicamycin, and improved the viability of the cells exposed to this agent. Exposure of the BRIN-BD11 cells to the protein phosphatase inhibitor, salubrinal, in the absence of fatty acids resulted in increased eIF2 phosphorylation but this was abolished by co-incubation with palmitoleate. We conclude that saturated fatty acids activate components of the PERK-dependent ER stress pathway in β-cells, ultimately leading to increased apoptosis. This effect is antagonised by monounsaturates that may exert their anti-apoptotic actions by regulating the activity of one or more kinase enzymes involved in mediating the phosphorylation of eIF2. |
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Fluctuations in the circulating levels of free fatty acids are probably important for the physiological regulation of insulin secretion in response to nutrients (Stein et al. 1996, Dobbins et al. 2002, Haber et al. 2003) but it is clear that a sustained elevation can be detrimental to pancreatic β-cells (Shimabukuro et al. 1998, Cnop et al. 2001, Piro et al. 2002). This response has been observed both in vivo and in vitro and is often termed ‘lipotoxicity’ (Newsholme et al. 2007, Poitout & Robertson 2008). Recent studies have suggested that the lipotoxic demise of the pancreatic β-cells may be related to a process of endoplasmic reticulum (ER) stress (Kharroubi et al. 2004, Karaskov et al. 2006, Eizirik et al. 2008) and that this culminates in enhanced cell loss by apoptosis. ER stress forms one component of a more general ‘integrated stress response’ displayed by mammalian cells (Ron & Walter 2007) which can subserve one of two apparently opposite functions. For example, the initial response to induction of ER stress culminates in the temporary inhibition of general protein synthesis which provides the cell with a window of opportunity during which it may recover from the stress stimulus and thereby restore normal homeostasis. However, if the stress stimulus is prolonged, then a secondary series of events is initiated which ultimately lead to the death of the cell by apoptosis (Ron 2002, Ron & Walter 2007). Thus, ER stress can be beneficial to a cell in the short term whereas it is detrimental if prolonged.
Increasing evidence implies that the activation of apoptosis in response to prolonged ER stress may underlie the death of β-cells achieved during chronic exposure to saturated fatty acids (Kharroubi et al. 2004, Karaskov et al. 2006, Eizirik et al. 2008, Laybutt et al. 2007). Hence, it follows from this, that manoeuvres designed to relieve ER stress might have beneficial effects on the β-cell and might promote their survival in the face of elevated saturated fatty acid levels. This concept is important since it has emerged that β-cell lipotoxicity results from the activation of specific pro-apoptotic pathways that are differentially regulated by saturated and monounsaturated molecules. Thus, while long-chain saturated fatty acids such as palmitate (C16:0) and stearate (C18:0) are powerfully lipotoxic to pancreatic β-cells, the equivalent monounsaturated molecules (palmitoleate (C16:1) and oleate (C18:1)) are potently cytoprotective under in vitro conditions (Welters et al. 2004, Diakogiannaki et al. 2007, Dhayal et al. 2008). In the present work, we have investigated the possibility that this may reflect a differential activation of the integrated stress response by saturated and monounsaturated fatty acids. Furthermore, we have considered the specific possibility that the cytoprotective actions of monounsaturates might be mediated by direct antagonism of the integrated stress response, leading to the maintenance of β-cell viability under conditions which would otherwise favour their demise.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
The rat pancreatic β-cell line BRIN-BD11 was used in all experiments. The cells were cultured in RPMI-1640 medium (Invitrogen) containing 11 mM glucose supplemented with 10% fetal calf serum (PAA Laboratories, Yeovil, Somerset, UK), 2 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin (Invitrogen). The cells were grown in 75 cm2 flasks at 37 °C and 5% CO2.
Treatment of cells with fatty acids
A stock solution of 50 mM palmitate (Sigma) was prepared in 50% ethanol by heating to 70 °C. Palmitoleate (MP Biomedicals, Cambridge, UK) and methyl palmitoleate (Sigma) were prepared by mixing with 90% ethanol at room temperature to produce stock solutions of 90 mM. The fatty acid preparations were then bound to 10% fatty acid-free BSA (MP Biomedicals) by incubation for 1 h at 37 °C. The mixture was added to RPMI-1640 medium (containing 11 mM glucose) deprived of fetal calf serum. The final concentrations present in the cell environment were 1% for BSA and 0.5% for ethanol. The cells were seeded into six-well plates at densities of 105 cells/well or 25 cm2 flasks and incubated for 24 h in complete RPMI-1640 medium. The medium was then removed and replaced with relevant fatty acid/BSA complexes (in RPMI-1640 devoid of fetal calf serum) for a further 18 h or as otherwise indicated. Controls received BSA and vehicle only.
Vital dye staining for estimation of viability
Following incubation, floating and attached cells were collected, centrifuged at 200 g for 5 min and resuspended in 250 µl complete RPMI-1640 plus 250 µl trypan blue (0.4% in PBS). Viable and dead cells were counted using a haemocytometer and the number of dead cells expressed as a percentage of the total for each condition.
Protein isolation: whole-cell extraction
Following incubation, cells were washed with ice-cold PBS and lysed with 0.5 ml lysis buffer (20 mM Tris, 150 mM NaCl, 1 mM EDTA, 1% Triton-X supplemented with 10 µl/ml protease inhibitor cocktail (Sigma) and 10 µl/ml phosphatase inhibitor cocktail 1 and 2 (Sigma)) per 75 cm2 flask, for 10 min. The flasks were scraped and the contents were transferred to microfuge tubes. Each sample was vortexed four times for 15 s and then centrifuged at 13 000 g for 10 min at 4 °C. The supernatant was retained for western blotting.
Protein isolation: nuclear and cytoplasmic protein extraction
The cells were cultured in 25 cm2 flasks, then washed with ice-cold PBS and lysed for 15 min with a low-salt lysis buffer consisting of 20 mM HEPES, 1 mM EDTA, 1 mM MgCl2, 10 mM KCl, 20% glycerol supplemented just before use with 10 µl/ml protease inhibitor cocktail (Sigma), 10 µl/ml phosphatase inhibitor cocktail 1 and 2 (Sigma), 1 mM dithiothreitol (DTT) and 0.5% Triton X-100. Cell lysates were transferred into microfuge tubes and centrifuged for 5 min at 2500 g. The supernatant constituted the cytoplasmic extract. The intact pellet was re-suspended in high-salt lysis buffer (400 mM NaCl, 20 mM HEPES, 1 mM EDTA, 1 mM MgCl2, 10 mM KCl, 20% glycerol, supplemented just before use with 10 µl/ml protease inhibitor cocktail (Sigma), 10 µl/ml phosphatase inhibitor cocktails 1 and 2 (Sigma) and 1 mM DTT). After 30 min of incubation with simultaneous shaking, the cell lysates were centrifuged for 30 min at 20 000 g. The supernatant was retained as the nuclear extract. Both cytoplasmic and nuclear fraction was assessed for protein content using the bicinchoninic acid protein assay (Perbio Science, Northumberland, UK).
Western blotting
With 7.5 µl 4x lauryl dodecyl sulphate (LDS) sample buffer (Invitrogen) and 3 µl β-mercaptoethanol (Sigma), 19.5 µl sample (diluted in lysis buffer to yield equal amounts of protein among samples–typically 50 µg were loaded) were mixed. The mixtures were heated at 90 °C for 10 min and loaded onto the gel. The gel was run in MOPS SDS running buffer (Invitrogen) at 200 V for approximately 1 h. The transfer of proteins from the gel to PVDF membrane was performed at 80 V and 250 mA overnight. The membrane was blocked in a solution containing 5% fatty acid-free milk powder dissolved in TBS supplemented with Tween 20 (0.05%) for 1 h at room temperature.
The following primary antibodies were used to probe membranes: activating transcription factor 4 (ATF4), GRP78 (Santa Cruz), eukaryotic initiation factor 2 (eIF2), p-eIF2 (Cell Signalling), CHOP-10, β-actin, histone H3 (Sigma). The dilution used in all cases was 1:1000. Incubation lasted for 4 h at room temperature. The membrane was then washed thrice with Tween–TBS for at least 5 min each time. The appropriate secondary antibody (anti-rabbit or anti-mouse IgG) was diluted in Tween–TBS containing 1% powdered milk (1:15 000) and incubated with the blot for 1 h at room temperature.
For the detection of bands, the chemiluminescent system ECL Plus (Amersham) was used. The membrane was exposed to film (Kodak BioMax) and the intensity of bands was quantified using a Fluor-S Multi-imager analysis system (Quantity One software Biorad UK Ltd). On some occasions, the membranes were stripped (0.2 M glycine, 1% SDS and 0.1%Tween, pH 2) for 10 min at room temperature with slight agitation and were then re-probed.
Electron microscopy
BRIN-BD11 cells were treated with fatty acids after seeding into 25 cm2 flasks. Cells were fixed in 2.5% glutaraldehyde (for 2 h), washed with 0.1 M sodium cacodylate buffer (three times) and postfixed in 1% osmium tetroxide for 2 h. The samples were dehydrated by sequential washings with increasing concentrations of ethanol (30, 50, 70 and 100%). Alcohol:resin mixtures of gradually increasing concentration (30, 50 and 70%) were used to infiltrate the cells. The samples were finally embedded in pure resin that was left to polymerise at 60–70 °C overnight. Ultra-thin sections were cut with a MicroStar diamond knife and attached to nickel grids. The samples were then negatively stained with a saturated solution of uranyl acetate in 70% ethanol followed by lead citrate. Images were collected on a JEOL 1200 EXII transmission electron microscope.
Data analysis
All experiments were performed on at least three separate occasions and triplicates of each condition were normally used in each experiment. The results are expressed as mean±S.E.M. and the level of significance was calculated by using Student's t-test or ANOVA and was regarded as significant when P<0.05.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
In previous studies, we have shown that treatment of BRIN-BD11 cells with palmitate leads to an increase in cell death mediated by apoptosis and that this response is attenuated when palmitoleate is included in the incubation medium (Welters et al. 2004, 2006, Diakogiannaki et al. 2007). In confirmation of these observations, it was observed in the present work that exposure of the cells to 250 µM palmitate for 18 h in the presence of BSA but no serum, resulted in a large loss of viability (control: 77±3% live cells; palmitate: 21±2%; P<0.001). By contrast, 250 µM palmitoleate was not toxic and even improved the viability beyond that seen under control conditions (90±3% live cells). Moreover, it completely prevented the loss of viability caused by palmitate (250 µM palmitate plus 250 µM palmitoleate: 92±3% live cells; P<0.001 relative to palmitate alone).
In view of these data obtained in cell viability experiments, we next employed electron microscopy to examine the morphology of β-cells following exposure to fatty acids. Examination of the images revealed that both of the metabolisable fatty acids tested (palmitate and palmitoleate) caused alterations to the cellular morphology (Fig. 1). However, important qualitative differences were noted. Thus, palmitate-treated cells displayed the most obvious changes in morphology with the appearance of widely distended intracellular membranes that were not seen in control cells (Fig. 1B and C). This could be indicative of structural changes to the ER since ribosomes were frequently seen in association with these distended membranes in palmitate-treated cells (Fig. 1H and I). Many of the cells also displayed the characteristic features of apoptosis, including condensation and margination of nuclear chromatin. Cells exposed to palmitoleate for the same period of time displayed less evidence of grossly altered morphology although moderate distension of the ER was still seen (Fig. 1D). β-cells treated with both palmitate and palmitoleate also displayed abnormal morphological features although, surprisingly, the ER distension was less extensive than in cells exposed to palmitate alone (Fig. 1E). Moreover, such cells did not have condensed and marginated chromatin, consistent with the improved viability associated with these incubation conditions (Welters et al. 2004, 2006, Diakogiannaki et al. 2007). Similar effects were noted following exposure of cells to the non-metabolisable unsaturated analogue, methyl palmitoleate, in the presence of palmitate although methyl palmitoleate itself failed to alter the cellular morphology (Fig. 1F and G).
|
To investigate whether the morphological changes to the ER observed in the electron micrographs were correlated with the activation of the ER stress pathways in fatty acid-treated cells, the expression of several markers of ER stress was studied. Three independent pathways of ER stress have been described and these are each regulated by different proteins localised to the ER membrane: PERK (RNA-dependent protein kinase-like endoplasmic reticulum eIF2 kinase), (IRE1) inositol requiring 1 and ATF4 (Harding & Ron 2002). Upon activation, each of these controls a distinct pathway that serves as an adaptive mechanism to promote the restoration of normal ER function. However, if ER stress is persistent then apoptosis can be initiated (Ron & Walter 2007, Sundar Rajan et al. 2007) and this frequently involves the induction of CHOP-10, a protein whose expression is increased by activation of any, or all, of the three ER stress pathways. Preliminary studies suggested that neither the IRE-1 nor the ATF6-dependent mechanism was involved in mediating fatty acid responses in BRIN-BD11 cells to a significant extent and, therefore, we focussed principally on the PERK-dependent pathway.
Culture of BRIN-BD11 cells in the presence of palmitate (0–0.15 mM) resulted in the induction of CHOP-10 in a dose-dependent manner (Fig. 2). By contrast, exposure of these cells to palmitoleate (even at concentrations as high as 1 mM) failed to promote CHOP-10 induction beyond that observed in control cells (Fig. 3). Controls consisted of cells cultured in serum-free medium plus BSA for 18 h and it is possible that these conditions may generate modest ER stress in the cells due to the absence of serum. This could, then, account for the low levels of CHOP-10 expression seen in the absence of fatty acids since incubation of cells in serum-replete medium was associated with minimal CHOP-10 expression (not shown). Tunicamycin was used as a positive control in these studies and, as expected, it caused a large rise in CHOP-10 expression, consistent with its ability to induce ER stress by promoting the accumulation of incorrectly folded proteins within this organelle. When the period of exposure to palmitoleate was increased to 42 h, CHOP-10 induction remained at a minimal level whereas tunicamycin caused a very large increase under these conditions (not shown).
|
|
|
|
this protein was also studied. Increased phosphorylation of eIF2 was detected in palmitate-treated cells but was not observed in response to palmitoleate. Furthermore, the palmitate-induced phosphorylation of eIF2 was inhibited by the presence of palmitoleate (Fig. 6), consistent with suppression of this arm of the ER stress response in cells exposed to the unsaturated fatty acid.
|
|
Since the above results indicate that exposure of β-cells to palmitoleate for 18 h not only fails to induce ER stress but also minimises the activation of ER stress initiated by palmitate, it was of interest to establish whether the monounsaturate also attenuates the ER stress response in cells exposed to tunicamycin. Therefore, cells were treated with tunicamycin in the absence or presence of palmitoleate and markers of the PERK-dependent ER stress response measured. These studies revealed that, even when present at a low concentration (25 µM), palmitoleate markedly reduced the expression of both CHOP-10 and ATF4 induced by tunicamycin (Fig. 8a). In the presence of a higher concentration of palmitoleate (0.25 mM) the effect was even more marked, although the reduction in expression of the markers was not completely returned to control levels. Palmitoleate also inhibited the phosphorylation of eIF2 induced by tunicamycin in BRIN-BD11 cells (Fig. 8b). In accord with these results, the loss of cell viability associated with exposure to tunicamycin was significantly attenuated when palmitoleate was present in the incubation medium (Fig. 9).
|
|
|
phosphorylation
Since we were able to detect a reduction in stimulus-dependent phosphorylation of eIF2 in cells exposed to palmitoleate, we next examined the possibility that an upstream kinase may be regulated in fatty acid-treated cells. The ER-associated kinase, PERK, frequently fulfils this role in response to ER stress but, somewhat surprisingly, we were unable to detect changes in PERK phosphorylation (an index of PERK activation since the phosphorylation reaction is autocatalytic) in response to palmitate or palmitoleate in BRIN-BD11 cells under conditions when thapsigargin caused an increase in phosphorylation (not presented). An alternative strategy was therefore adopted by examining the effects of palmitoleate in the presence of a protein phosphatase (PP) inhibitor, salubrinal (Boyce et al. 2005). This agent is reported to act as a selective inhibitor of PP1 which mediates dephosphorylation of eIF2 in the ER stress cascade. In accordance with this, exposure of BRIN-BD11 cells to 25 µM salubrinal alone resulted in a net increase in the level of phospho-eIF2 over 24 h (Fig. 11). This response was maintained for up to 72 h in the continued presence of salubrinal (not shown) and probably reflects the interruption of a constitutive cycle operating between the phospho- and native forms in unstimulated cells. Palmitoleate did not reproduce this response to salubrinal suggesting that it does not inhibit PP1 activity but, strikingly, the monounsaturate dramatically reduced the level of phospho-eIF2 in cells exposed to salubrinal. This implies that palmitoleate may exert its influence by inhibiting the activity of a kinase responsible for phosphorylation of eIF2 in BRIN-BD11 cells.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
The functional differences seen upon exposure of BRIN-BD11 β-cells to saturated (palmitate) and monounsaturated (palmitoleate) fatty acids are correlated, in part, with differences in cell morphology. In particular, electron microscopic analysis revealed that exposure of the cells to palmitate (C16:0) caused severe morphological abnormalities that were manifest principally as distended intracellular membrane structures. Similar observations were made recently by Moffitt et al. (2005) and Lai et al (2008) in β-cells. Examination of the affected membranes revealed that these were frequently decorated with ribosomes and it seems likely, therefore, that the changes represent structural modifications to the ER. Most of the cells displayed such changes and, in some cases, the distended membranes occupied much of the intracellular space.
Exposure of cells to palmitoleate (C16:1) caused qualitatively similar changes to the intracellular architecture but, in this case, the extent of membrane distension was much less extensive. This suggests that the incorporation of monounsaturated fatty acids into membrane lipids is less destructive to membrane architecture than when saturated molecules are present. However, the most surprising result was observed when the two species of fatty acid were applied in combination. Under these conditions (when the total fatty acid concentration was double that achieved with either molecule alone), the extent of cell damage was no greater than that seen with palmitate alone. Indeed, examination of multiple images revealed that there was a diminution of the overall extent of membrane distension compared with palmitate alone.
The presence of potential morphological alterations to the ER prompted an examination of relevant biochemical markers which might indicate the development of ER stress during exposure to fatty acids. Such studies revealed that the transcription factors ATF4 and CHOP-10 were markedly induced in BRIN-BD11 cells exposed to palmitate, which is consistent with the operation of at least one arm of the ER stress pathway. In support of this, phosphorylation of the initiation factor, eIF2 was also increased suggesting that activation of the PERK-dependent arm of ER stress had occurred. However, no consistent induction of the ER chaperone, GRP78, was observed; a result that confirms recent findings in β-cells (Karaskov et al. 2006, Lai et al. 2008) but was unexpected given the primary involvement of this protein in regulating protein folding during ER stress and in activation of the PERK-dependent pathway (Eizirik et al. 2008, Ron & Walter 2007). Thus, exposure of cells to palmitate caused morphological abnormalities that are consistent with altered ER disposition and led to induction of certain distal components of the ER stress pathway. However, full activation of the PERK-dependent ER stress response was not seen. This conclusion is also consistent with other recent findings of Karaskov et al (2006) who noted that ER Ca2+ stores do not become depleted during fatty acid cytotoxicity in β-cells, although, in contrast to the present work, these authors did observe evidence of PERK activation in palmitate-treated cells. When cells were treated with tunicamycin, an inhibitor of N-linked protein glycosylation in the ER, marked up-regulation of all of the components studied was observed (including GRP78, p-eIF2, ATF4 and CHOP-10). Thus, exposure of β-cells to palmitate appears to activate some components of the integrated stress response that is sufficient to promote cell loss by apoptosis. Changes in ER stress markers have recently been observed in the islets of patients with type 2 diabetes (Huang et al. 2007, Marchetti et al. 2007) suggesting that ER stress might contribute to the progressive loss of β-cells which occurs in this condition, although it is not yet clear whether this reflects exposure of β-cells to elevated levels of saturated fatty acids in vivo.
In BRIN-BD11 cells, the activation of components of the ER stress pathway by palmitate was largely confined to the PERK-dependent arm whereas other workers have observed significant activation of additional ER stress pathways (Kharroubi et al. 2004, Karaskov et al. 2006). The reasons for this difference are not clear but it is noteworthy that Lai et al. (2008) recently reported selective activation of the PERK-dependent pathway when INS-1 cells were exposed to low concentration of palmitate (Lai et al. 2008). Thus, it is possible that differences in the free fatty acid concentrations achieved (which are dramatically influenced by proteins present in the incubation medium) may influence the extent to which each pathway is activated and that the PERK arm responds to lower palmitate concentrations.
Exposure of BRIN-BD11 cells to palmitoleate for 18 h failed to cause the induction of any of the markers of ER stress investigated, thereby revealing a critical difference in the biochemical response of the cells to saturated and monounsaturated fatty acids. This result is consistent with other data obtained recently in additional pancreatic β-cell lines (Karaskov et al. 2006, Laybutt et al. 2007) and in hepatocytes (Wei et al. 2006). More surprisingly, however, we observed that, despite its failure to normalise the altered morphology of palmitate-treated cells, palmitoleate markedly suppressed the induction of ER stress markers in palmitate-treated cells. Thus, the phosphorylation of eIF2 and the induction of both ATF4 and CHOP-10 were attenuated in cells treated with palmitate plus palmitoleate when compared with those exposed to palmitate alone. Since, however, this occurred in the absence of any alteration in GRP78 expression during exposure to fatty acids, this implies that the response to palmitoleate was not initiated by a change in GRP78 expression but that the monounsaturate intervenes at a more distal point in the pathway. In this context, it is interesting to note that Lai et al. (2008) have recently reported that altered expression of GRP78 does not modify the loss of viability seen in β-cells exposed to fatty acids.
The results also revealed, for the first time, that palmitoleate attenuated the activation of ER stress in cells exposed to tunicamycin, thereby demonstrating that the protective response is not restricted only to the activation of ER stress by saturated fatty acids. Moreover, the loss of cell viability arising from the presence of tunicamycin was also inhibited by palmitoleate, confirming our earlier conclusion that the monounsaturate can regulate cell death induced by a variety of different stimuli in β-cells (Welters et al. 2004, Diakogiannaki et al. 2007).
In order to examine, in more detail, the mechanisms by which the PERK-dependent arm of ER stress is attenuated by palmitoleate, the phosphorylation of eIF2 was studied. Phosphorylation of eIF2 represents a key triggering event in the pathway and the reaction can be catalysed by any one of the several cellular kinases (Rutkowski & Kaufman 2003). As such, it represents a bifurcation point within the ER stress pathway at which other stimuli (some of which may act independently of ER stress) can intervene. Thus, activation of one or more of these alternative kinases can elicit the downstream responses associated with ER stress without necessarily inducing ER stress itself. The dephosphorylation of eIF2 is catalysed by PP1 and this enzyme is a selective target for the drug, salubrinal, which inhibits de-phosphorylation of the initiation factor (Boyce et al. 2005). Therefore, in order to investigate the possible involvement of altered eIF2 phosphorylation in mediating the actions of palmitoleate, the response to salubrinal was examined.
As reported recently in PC12 cells (Boyce et al. 2005) and in primary rodent β-cells (Cnop et al. 2007), exposure of BRIN-BD11 cells to salubrinal maintained eIF2 in a phosphorylated state. However, when palmitoleate was added in the simultaneous presence of salubrinal, the extent of phosphorylation of eIF2 was decreased. Since, under these conditions, the phosphatase activity was restrained by salubrinal, these data could be taken to indicate that palmitoleate acted to inhibit the activity of an eIF2 kinase (rather than promoting an increase in phosphatase activity). It should also be acknowledged, however, that palmitoleate may have simply impaired the action of salubrinal, although this mechanism would not provide a satisfactory explanation for its capacity to attenuate eIF2 phosphorylation in response to other stimuli. If palmitoleate does restrain the activity of an eIF2 kinase, then this does not necessarily imply that its actions are mediated directly since intermediate steps could be involved.
In considering these issues, it is important to note the recent proposal of Yusta et al. (2006) that protein kinase A (PKA) may be a critical mediator of the anti-apoptotic effects of the GLP-1 receptor agonist exendin-4 in purified rat β-cells (Yusta et al. 2006). This effect is secondary to a rise in cAMP and the authors show that the ensuing activation of PKA regulates several components of the ER stress pathway in β-cells. However, we consider it unlikely that PKA plays a role in mediating the effects of palmitoleate reported here since this fatty acid does not increase cAMP levels in BRIN-BD11 cells (Welters et al. 2006).
Taken together, the present results reveal that some, though not all, components of the PERK-dependent arm of the integrated stress response are activated in BRIN-BD11 cells exposed to palmitate. By contrast, in cells treated with palmitoleate, the integrated stress response remains silent. Exposure of β-cells to both palmitate and palmitoleate leads to attenuation of the integrated stress pathway and a similar response is seen in cells incubated with tunicamycin. We propose that these effects may reflect the diminished activation of an eIF2 kinase(s) in response to palmitoleate. As such, it seems possible that palmitoleate does not simply relieve ER stress at its point of initiation in β-cells (as evidenced by the failure of palmitoleate to block completely the morphological changes to the ER seen in palmitate-treated cells) but, rather, it intervenes to inhibit the effector arm of one of the pathways by which prolonged ER stress elicits an increase in apoptosis.
|
Acknowledgements |
|---|
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Boyce M, Bryant KF, Jousse C, Long K, Harding HP, Scheuner D, Kaufman RJ, Ma D, Coen DM, Ron D et al. 2005 A selective inhibitor of eIF2 dephosphorylation protects cells from ER stress. Science 307 935–939.
Carpentier A, Mittelman SD, Bergman RN, Giacca A & Lewis GF 2000 Prolonged elevation of plasma free fatty acids impairs pancreatic β-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. Diabetes 49 399–408.[Abstract]
Cnop M, Hannaert JC, Hoorens A, Eizirik DL & Pipeleers DG 2001 Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes 50 1771–1777.
Cnop M, Ladriere L, Hekerman P, Ortis F, Cardozo AK, Dogusan Z, Flamez D, Boyce M, Yuan J & Eizirik DL 2007 Selective inhibition of eukaryotic translation initiation factor 2 alpha dephosphorylation potentiates fatty acid-induced endoplasmic reticulum stress and causes pancreatic β-cell dysfunction and apoptosis. Journal of Biological Chemistry 282 3989–3997.
Dhayal S, Welters H & Morgan NG 2008 Structural requirements for the cytoprotective actions of mono-unsaturated fatty acids in the pancreatic β-cell line, BRIN-BD11. British Journal of Pharmacology In press.
Diakogiannaki E, Dhayal S, Childs CE, Calder PC, Welters HJ & Morgan NG 2007 Mechanisms involved in the cytotoxic and cytoprotective actions of saturated versus monounsaturated long-chain fatty acids in pancreatic β-cells. Journal of Endocrinology 194 283–291.
Dobbins RL, Szczepaniak LS, Myhill J, Tamura Y, Uchino H, Giacca A & McGarry JD 2002 The composition of dietary fat directly influences glucose-stimulated insulin secretion in rats. Diabetes 51 1825–1833.
Eizirik DL, Cardozo AK & Cnop M 2008 The role for endoplasmic reticulum stress in diabetes mellitus. Endocrine Reviews 29 42–61.
Gordon ES 1960 Non-esterified fatty acids in the blood of obese and lean subjects. American Journal of Clinical Nutrition 8 740–747.[Web of Science]
Haber EP, Ximenes HM, Procopio J, Carvalho CR, Curi R & Carpinelli AR 2003 Pleiotropic effects of fatty acids on pancreatic β-cells. Journal of Cellular Physiology 194 1–12.[CrossRef][Web of Science][Medline]
Harding HP & Ron D 2002 Endoplasmic reticulum stress and the development of diabetes: a review. Diabetes 51 S455–S461.
Huang CJ, Lin CY, Haataja L, Gurlo T, Butler AE, Rizza RA & Butler PC 2007 High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated β-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes. Diabetes 56 2016–2027.
Karaskov E, Scott C, Zhang L, Teodoro T, Ravazzola M & Volchuk A 2006 Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis. Endocrinology 147 3398–3407.
Kharroubi I, Ladriere L, Cardozo AK, Dogusan Z, Cnop M & Eizirik DL 2004 Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology 145 5087–5096.
Lai E, Bikopoulos G, Wheeler MB, Rozakis-Adcock M & Volchuk A 2008 Differential activation of ER stress and apoptosis in response to chronically elevated free fatty acids in pancreatic β-cells. American Journal of Physiology. Endocrinology and Metabolism 294 E540–E550.
Laybutt DR, Preston AM, Akerfeldt MC, Kench JG, Busch AK, Biankin AV & Biden TJ 2007 Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 50 752–763.[CrossRef][Web of Science][Medline]
Maedler K, Oberholzer J, Bucher P, Spinas GA & Donath MY 2003 Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic β-cell turnover and function. Diabetes 52 726–733.
Marchetti P, Bugliani M, Lupi R, Marselli L, Masini M, Boggi U, Filipponi F, Weir GC, Eizirik DL & Cnop M 2007 The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients. Diabetologia 50 2486–2494.[CrossRef][Web of Science][Medline]
Newsholme P, Keane D, Welters HJ & Morgan NG 2007 Life and death decisions of the pancreatic β-cell: the role of fatty acids. Clinical Science 112 27–42.[CrossRef][Web of Science][Medline]
Oprescu AI, Bikopoulos G, Naassan A, Allister EM, Tang C, Park E, Uchino H, Lewis GF, Fantus IG, Rozakis-Adcock M et al. 2007 Free fatty acid-induced reduction in glucose-stimulated insulin secretion: evidence for a role of oxidative stress in vitro and in vivo. Diabetes 56 2927–2937.
Oyadomari S & Mori M 2004 Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death and Differentiation 11 381–389.[CrossRef][Web of Science][Medline]
Piro S, Anello M, Di Pietro C, Lizzio MN, Patane G, Rabuazzo AM, Vigneri R, Purrello M & Purrello F 2002 Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. Metabolism 51 1340–1347.[CrossRef][Web of Science][Medline]
Poitout V & Robertson RP 2008 Glucolipotoxicity: fuel excess and β-cell dysfunction. Endocrine Reviews In press.
Ron D 2002 Translational control in the endoplasmic reticulum stress response. Journal of Clinical Investigation 110 1383–1388.[CrossRef][Web of Science][Medline]
Ron D & Walter P 2007 Signal integration in the endoplasmic reticulum unfolded protein response. Nature Review. Molecular and Cellular Biology 8 519–529.[CrossRef]
Rutkowski DT & Kaufman RJ 2003 All roads lead to ATF4. Developmental Cell 4 442–444.[CrossRef][Web of Science][Medline]
Sabin MA, De Hora M, Holly JM, Hunt LP, Ford AL, Williams SR, Baker JS, Retallick CJ, Crowne EC & Shield JP 2007 Fasting nonesterified fatty acid profiles in childhood and their relationship with adiposity, insulin sensitivity, and lipid levels. Pediatrics 120 e1426–e1433.
Shimabukuro M, Zhou YT, Levi M & Unger RH 1998 Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. PNAS 95 2498–2502.
Stein DT, Esser V, Stevenson BE, Lane KE, Whiteside JH, Daniels MB, Chen S & McGarry JD 1996 Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. Journal of Clinical Investigation 97 2728–2735.[Web of Science][Medline]
Sundar Rajan S, Srinivasan V, Balasubramanyam M & Tatu U 2007 Endoplasmic reticulum (ER) stress and diabetes. Indian Journal of Medical Research 125 411–424.[Web of Science][Medline]
Unger RH 1995 Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 44 863–870.[Abstract]
Wei Y, Wang D, Topczewski F & Pagliassotti MJ 2006 Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. American Journal of Physiology. Endocrinology and Metabolism 291 E275–E281.
Welters HJ, Tadayyon M, Scarpello JH, Smith SA & Morgan NG 2004 Mono-unsaturated fatty acids protect against β-cell apoptosis induced by saturated fatty acids, serum withdrawal or cytokine exposure. FEBS Letters 560 103–108.[CrossRef][Web of Science][Medline]
Welters HJ, Diakogiannaki E, Mordue JM, Tadayyon M, Smith SA & Morgan NG 2006 Differential protective effects of palmitoleic acid and cAMP on caspase activation and cell viability in pancreatic β-cells exposed to palmitate. Apoptosis 11 1231–1238.[CrossRef][Web of Science][Medline]
Yusta B, Baggio LL, Estall JL, Koehler JA, Holland DP, Li H, Pipeleers D, Ling Z & Drucker DJ 2006 GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress. Cell Metabolism 4 391–406.[CrossRef][Web of Science][Medline]
Zhou YP & Grill VE 1994 Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. Journal of Clinical Investigation 93 870–876.[Web of Science][Medline]
Received in final form 19 March 2008
Accepted 20 March 2008
Made available online as an Accepted Preprint 20 March 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
